$4.30
-0.19-4.23%
At close: -
$4.30
0.000.00%
After Hours: 4:00 PM EDT
Cytek Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cytek Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $0.07 | $0.10 | -30.0 % |
Q3 | 2024-11-05 | $0.01 | $-0.01 | 200.0 % |
Q2 | 2024-08-06 | $-0.08 | $-0.03 | -166.7 % |
Q1 | 2024-05-08 | $-0.05 | $-0.04 | -25.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $57.48M | $59.38M | -3.21 % |
Q3 | 2024-11-05 | $51.50M | $50.70M | 1.58 % |
Q2 | 2024-08-06 | $46.62M | $49.53M | -5.88 % |
Q1 | 2024-05-08 | $44.86M | $43.55M | 3.01 % |
Cytek Biosciences (CTKB) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
The Actual EPS was $0.07, which missed the estimate of $0.10.
The Actual Revenue was $57.5M, which missed the estimate of $59.4M.
Browse earnings estimates, EPS, and revenue on all stocks.